HATBORO, PA — Azzur Group has announced the launch of analytical laboratory testing services for advanced therapeutic medicinal products (ATMPs). This new offering comes at a time when more than 3,000 advanced therapies are in development worldwide, with 124 already approved.
These ATMPs represent some of the most promising and innovative areas of medicine today, including gene therapy, tissue engineering, and somatic cell therapy. Their development and approval are transforming therapeutic options, offering new hope for patients with conditions that were previously untreatable.
Azzur Group’s innovative testing services are dedicated to supporting the development of these cutting-edge therapies. The company’s robust capabilities are firmly grounded in safety, quality, and product stability, meticulously crafted to meet the stringent regulatory requirements associated with Advanced Therapy Medicinal Products (ATMPs).
“When developing advanced therapeutics for patients, speed and compliance are critical,” said Jorge Marques Signes, PhD, Vice President of Advanced Therapies Services at Azzur Group. “Expertise and time dedicated to method development, quality control testing, and validating analytical procedures are fundamental to success.”
The company’s latest offering encompasses assay and protocol development, meticulous study design and execution, as well as cutting-edge analytical and bioanalytical testing services. This comprehensive suite of solutions is meticulously crafted to provide a holistic approach for the advancement of cell and gene therapy development and manufacturing, ensuring a seamless and efficient process from inception to completion.
One key component of this solution is Azzur Cleanrooms on Demand™. This service combines manufacturing infrastructure, compliance expertise, and training, relieving clients of the burden of facility ownership. Azzur Group’s model is designed to be flexible and adaptable, meeting the specific demands of the pipeline lifecycle.
The importance of these testing services cannot be overstated. In the rapidly evolving field of advanced therapeutics, ensuring safety, quality, and efficacy is paramount. With stringent regulatory scrutiny and high stakes for patient health, comprehensive testing and validation are critical.
Azzur Group’s entry into this space represents a significant support for biotech companies working on the frontier of medical innovation. By providing expert testing services, Azzur Group is helping to enable the delivery of novel cell and gene therapies that have the potential to revolutionize medicine and greatly enhance patient lives.
“The comprehensive Azzur approach to advanced therapeutics offers clients a model of speed and adaptability that will revolutionize manufacturing flexibility in the industry,” said Sarah Stevens, PhD, President of Azzur Labs and Azzur Cleanrooms on Demand™.
For those closely following the industry, the recent introduction of Azzur Group’s ATMP Analytical Services marks a noteworthy milestone. As the realm of advanced therapeutics propels the frontiers of medical possibilities, the demand for specialized testing and validation services is poised to expand exponentially. Azzur Group’s latest service launch not only signifies a strategic move but also underscores its commitment to becoming a prominent figure in this dynamic and groundbreaking sector.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.